Emerging Trends to Reshape the Global Cell And Gene Therapy Supply Chain/Logistics Market: Advancements In Technology Propel Cell And Gene Therapy Logistics as a Key Influencer

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cell And Gene Therapy Supply Chain/Logistics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market encompassing cell and gene therapy supply chain and logistics has experienced swift expansion lately, projected to increase from a value of $1.41 billion in 2024 to $1.57 billion in 2025, reflecting an 11.5% compound annual growth rate; the factors driving this historical upward trajectory include the increasing incidence of long-term illnesses, optimized application of supply chain necessities, enhanced methods for preserving drug efficacy, the development of more mature regulatory structures, and a heightened focus on both managing potential risks and adhering to established regulations.

Cell And Gene Therapy Supply Chain/Logistics Market Size Forecast: What's the Projected Valuation by 2029?
Anticipation is for significant expansion within the cell and gene therapy supply chain and logistics sector over the forthcoming years, with the market set to achieve a valuation of $2.44 billion by 2029, driven by an 11.5% compound annual growth rate; this projected upswing is fundamentally linked to the broader proliferation of personalized medicine approaches, advancements in cell-free therapeutic modalities, the increasing occurrence of long-term illnesses globally, the burgeoning cell therapy production industry worldwide, and the effective execution of supply chain mandates. Key developments shaping this trend encompass heightened spending on research and development activities, the integration of cutting-edge technological solutions, the establishment of supportive regulatory frameworks and programs designed to enhance accessibility, strategic alliances formed among entities in cell and gene therapy, logistics provision, and supply chain management, alongside the offering of tailor-made services designed to accommodate patient identification at various critical stages.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

What Are the Drivers Transforming the Cell And Gene Therapy Supply Chain/Logistics Market?
The escalating demand for cell and gene therapies is propelling growth within the cell and gene therapy supply chain, also known as the logistics market, as these sophisticated treatments necessitate precise handling from acquisition through distribution and warehousing, due to their requirement for stringent temperature controls and specific storage environments to effectively address diseases with potentially curative modifications to human cells or genes; this burgeoning field's significance is highlighted by data from the American Society of Gene & Cell Therapy, a US-based body focused on medical and scientific advancement, which reported a 10 percent uptick in US-based gene therapies entering Phase III clinical trials during the third quarter of 2023, marking the initial quarterly rise since the third quarter of 2022, thereby underscoring how the rising requirement for these advanced cellular and genetic interventions fuels the momentum of the associated supply chain and logistics infrastructure.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp

What Long-Term Trends Will Define the Future of the Cell And Gene Therapy Supply Chain/Logistics Market?
A significant shift in the landscape of the cell and gene therapy logistics and supply chain sector is the increasing prevalence of advanced technological platforms. Leading participants are engineering these cutting-edge technological systems specifically for cell and gene therapies as a means to secure and enhance their standing within the industry. To illustrate this, the US healthcare entity AmerisourceBergen Corporation, known for its expertise in this specialized supply chain, introduced its Cell and Gene Therapy (CGT) Integration Hub in April 2023. This CGT Integration Hub leverages the proprietary, advanced customer relationship management (CRM) software developed by AmerisourceBergen and is designed for seamless incorporation with biopharma platforms, thereby offering superior oversight capabilities for both the progression and the distribution phases of cell and gene therapies.

Which Segments in the Cell And Gene Therapy Supply Chain/Logistics Market Offer the Most Profit Potential?
The cell and gene therapy supply chain/logisticsmarket covered in this report is segmented -

1) By Type Of Software Solution: Cell Orchestration Platform; Enterprise Manufacturing System; Inventory Management System; Laboratory Information Management System; Logistics Management System; Patient Management System; Quality Management System; Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution; On-Premises Solution
3) By Component: Cryogenic Shippers; Cryogenic Storage Freezers; Ultra-Low Freezers; Cold Chain Management Systems; Shipment; Storage Medium; Cryogenic Packout Kits; Other Components
4) By Application Area: Donor Eligibility Assessment; Sample Collection; Manufacturing; Logistics; Patient Verification; Treatment Follow-Up
5) By End User: Biobank; Cell Therapy Lab; Hospital; Research Institute; Commercial Organization

Subsegments:
1) By Cell Orchestration Platform: Workflow Management; Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control; Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management; Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management; Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning; Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination; Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking; Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments; Chain Of Custody Documentation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12631&type=smp

Which Firms Dominate the Cell And Gene Therapy Supply Chain/Logistics Market by Market Share and Revenue in 2025?
Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

Which Regions Offer the Highest Growth Potential in the Cell And Gene Therapy Supply Chain/Logistics Market?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12631

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.